— Know what they know.
Not Investment Advice

CABA NASDAQ

Cabaletta Bio, Inc.
1W: -3.4% 1M: -44.0% 3M: -33.5% YTD: -9.5% 1Y: -13.4% 3Y: -86.4% 5Y: -83.3%
$2.00
+0.11 (+5.82%)
 
Weekly Expected Move ±11.0%
$2 $2 $2 $2 $2
NASDAQ · Healthcare · Biotechnology · Tech Score Strong Sell · Power 28 · $326.1M mcap · 143M float · 3.50% daily turnover · Short 43% of daily vol

Balance Sheet Trends

Total Assets
$165M -10.8% ▼
5Y CAGR: +7.5%
Total Liabilities
$53M +62.1% ▲
5Y CAGR: +59.2%
Shareholders Equity
$112M -26.4% ▼
5Y CAGR: +0.5%
Cash & Investments
$134M -18.5% ▼
5Y CAGR: +4.2%
Total Debt
$27M +73.7% ▲
Net Debt
-$56M +62.3% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$122M$82M$193M$164M$83M
Short-Term Investments$0$25M$48M$0$51M
Cash & ST Investments$122M$107M$241M$164M$134M
Net Receivables$0$0$0$0$0
Inventory$0$0$0$0$0
Other Current Assets$2M$2M$0$3M$5M
Total Current Assets$125M$109M$244M$167M$139M
Property, Plant & Equip.$1M$8M$7M$16M$21M
Goodwill & Intangibles$0$0$0$0$0
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$357K$565K$2M$6M$5M
Total Non-Current Assets$2M$8M$9M$22M$26M
Total Assets$126M$117M$254M$185M$165M
— Liabilities —
Accounts Payable$2M$2M$5M$5M$7M
Short-Term Debt$0$0$0$0$24M
Deferred Revenue$0$0$0$0$0
Other Current Liabilities$3M$1M$40K$8M$19M
Total Current Liabilities$8M$9M$16M$27M$50M
Long-Term Debt$0$0$0$0$3M
Other Non-Current Liab.$0$0$0$0$0
Total Non-Current Liabilities$0$3M$1M$6M$3M
Total Liabilities$8M$12M$17M$33M$53M
— Equity —
Common Stock$0$0$0$1K$1K
Retained Earnings-$113M-$166M-$233M-$349M-$517M
Accumulated OCI$0-$47K$39K$0$25K
Total Stockholders Equity$118M$105M$236M$152M$112M
Total Liabilities & Equity$126M$117M$254M$185M$165M
— Key Metrics —
Total Debt$0$5M$5M$16M$27M
Net Debt-$122M-$76M-$188M-$148M-$56M
Total Investments$0$25M$48M$0$51M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms